In situ loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumor-directed immunity

References

• Oosterhoff D, Sluijter BJR, Hangalapura BN, de Gruijl, TD. The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanoma. Curr Top Microbiol Immunol 2012 351:181-220; PMID:21681685
   PubMed Web of Science ®Google Scholar
• Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L, Briere F, Chaussabel D, Zurawski G, Palucka aK, Reiter Y, Banchereau J, Ueno H. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008 29:497-510; PMID:18789730; http://dx.doi.org/10.1016/j.immuni.2008.07.013
   PubMed Web of Science ®Google Scholar
• Matthews K, Chung NPY, Klasse PJ, Moutaftsi M, Carter D, Salazar AM, Reed SG, Sanders RW, Moore JP. Clinical Adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells. PLoS One 2013 8:e63785; PMID:23700434; http://dx.doi.org/10.1371/journal.pone.0063785
   PubMed Web of Science ®Google Scholar
• Van de Ven R, van den Hout MFCM, Lindenberg JJ, Sluijter BJR, van Leeuwen PaM, Lougheed SM, Meijer S, van den Tol MP, Scheper RJ, de Gruijl TD. Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation. Blood 2011 118:2502-10; PMID:21750314; http://dx.doi.org/10.1182/blood-2011-03-344838
   PubMed Web of Science ®Google Scholar
• Santegoets SJaM, Gibbs S, Kroeze K, van de Ven R, Scheper RJ, Borrebaeck Ca, de Gruijl TD, Lindstedt M. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol 2008 84:143-51; PMID:18436579; http://dx.doi.org/10.1189/jlb.1107750
   PubMed Web of Science ®Google Scholar
• Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993 151:6535-45; PMID:7504023
   PubMed Web of Science ®Google Scholar
• Turville SG, Cameron PU, Handley A, Lin G, Pöhlmann S, Doms RW, Cunningham AL. Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 2002 3:975-83; PMID:12352970; http://dx.doi.org/10.1038/ni841
   PubMed Web of Science ®Google Scholar
• Kaplan DH. In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol 2010 31:446-51; PMID:21035396; http://dx.doi.org/10.1016/j.it.2010.08.006
   PubMed Web of Science ®Google Scholar
• Larregina AT, Morelli AE, Spencer LA, Logar AJ, Watkins SC, Thomson AW, Falo LD. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2001 2:1151-8; PMID:1170206-5; http://dx.doi.org/10.1038/ni731
   PubMed Web of Science ®Google Scholar
• Geissmann F, Prost C, Monnet J.-P, Dy M, Brousse N, Hermine O. Transforming growth factor 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic langerhans cells. J Exp Med 1998 187:961-6; PMID:9500798; http://dx.doi.org/10.1084/jem.187.6.961
   PubMed Web of Science ®Google Scholar
• De Gruijl TD, Sombroek CC, Lougheed SM, Oosterhoff D, Buter J, van den Eertwegh AJM, Scheper RJ, Pinedo HM. A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance. J Immunol 2006 176:7232-42; PMID:16751366; http://dx.doi.org/10.4049/jimmunol.176.12.7232
   PubMed Web of Science ®Google Scholar
• Lindenberg JJ, Oosterhoff D, Sombroek CC, Lougheed SM, Hooijberg E, Stam AGM, Santegoets SJAM, Tijssen HJ, Buter J, Pinedo HM, et al. IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation. PLoS One 2013 8:e70237; PMID:23875023; http://dx.doi.org/10.1371/journal.pone.0070237
   PubMedGoogle Scholar
• Santegoets SJaM, Bontkes HJ, Stam AGM, Bhoelan F, Ruizendaal JJ, van den Eertwegh AJM, Hooijberg E, Scheper RJ, de Gruijl TD. Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model. J Immunol 2008 180:4540-9; PMID:18354176; http://dx.doi.org/10.4049/jimmunol.180.7.4540
   PubMed Web of Science ®Google Scholar
• Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M, Fatho M, Lennerz V, Wölfel T, Hölzel M, et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 2012 490:412-6; PMID:23051752; http://dx.doi.org/10.1038/nature11538
   PubMed Web of Science ®Google Scholar
• Doubrovina E, Carpenter T, Pankov D, Selvakumar A, Hasan A, O’Reilly RJ. Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias. Blood 2012 120:1633-46; PMID:22623625; http://dx.doi.org/10.1182/blood-2011-11-394619
   PubMed Web of Science ®Google Scholar
• Stevanovic S. Identification of tumour-associated T-cell epitopes for vaccine development. Nat Rev Cancer 2002 2:514-20; PMID:12094237; http://dx.doi.org/10.1038/nrc841
   PubMed Web of Science ®Google Scholar
• Van Rooij N, van Buuren MM, Philips D, Velds A, Toebes M, Heemskerk B, van Dijk LJA, Behjati S, Hilkmann H, El Atmioui D, et al. Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. J Clin Oncol 2013 31:e439-42; PMID:24043743; http://dx.doi.org/10.1200/JCO.2012.47.7521
   PubMed Web of Science ®Google Scholar
• Lomonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008 27 Suppl 1: S2-S19; PMID:19641503; http://dx.doi.org/10.1038/onc.2009.39
   PubMedGoogle Scholar
• Franz S, Herrmann K, Fürnrohr BG, Führnrohr B, Sheriff A, Frey B, Gaipl US, Voll RE, Kalden JR, Jäck H-M, et al. After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ 2007 14:733-42; PMID:17170754; http://dx.doi.org/10.1038/sj.cdd.4402066
   PubMed Web of Science ®Google Scholar
• Lane JD, Allan VJ, Woodman PG. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J Cell Sci 2005 118:4059-71; PMID:16129889; http://dx.doi.org/10.1242/jcs.02529
   PubMed Web of Science ®Google Scholar
• Fransen JH, Hilbrands LB, Ruben J, Stoffels M, Adema GJ, van der Vlag J, Berden JH. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum 2009 60:2304-13; PMID:19644874; http://dx.doi.org/10.1002/art.24719
   PubMed Web of Science ®Google Scholar
• Ruben JM, van den Ancker W, Bontkes HJ, Westers TM, Hooijberg E, Ossenkoppele GJ, de Gruijl TD, van de Loosdrecht AA. Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines. Cancer Immunol Immunother 2014 63:335-45; PMID:24384837; http://dx.doi.org/10.1007/s00262-013-1515-6
   PubMed Web of Science ®Google Scholar
• Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K., Steinman RM. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002 196:1091-7; PMID:12391020; http://dx.doi.org/10.1084/jem.20021215
   PubMed Web of Science ®Google Scholar
• Morelli aE. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant 2006 6:254-61; PMID:16426309; http://dx.doi.org/10.1111/j.1600-6143.2005.01197.x
   PubMed Web of Science ®Google Scholar
• Ren G, Su J, Zhao X, Zhang L, Zhang J, Roberts AI, Zhang H, Das G, Shi Y. Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-gamma and nitric oxide. J Immunol 2008 181:3277-84; PMID:18713999; http://dx.doi.org/10.4049/jimmunol.181.5.3277
   PubMed Web of Science ®Google Scholar
• De Gruijl TD, Luykx-de Bakker SA, Tillman BW, van den Eertwegh AJM, Buter J, Lougheed SM, van der Bij GJ, Safer AM, Haisma HJ, Curiel DT, et al. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J Immunol 2002 169:5322-31; PMID:12391253; http://dx.doi.org/10.4049/jimmunol.169.9.5322
   PubMed Web of Science ®Google Scholar
• Oosterhoff D, Heusinkveld M, Lougheed SM, Kosten I, Lindstedt M, Bruijns SCM, van Es T, van Kooyk Y, van der Burg SH, de Gruijl TD. Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans. J Immunol 2013 190:3338-45; PMID:23467931; http://dx.doi.org/10.4049/jimmunol.1200598
   PubMed Web of Science ®Google Scholar
• Hooijberg E, Ruizendaal JJ, Snijders PJ, Kueter EW, Walboomers JM, Spits H. Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase. J Immunol 2000 165:4239-45; PMID:11035057; http://dx.doi.org/10.4049/jimmunol.165.8.4239
   PubMed Web of Science ®Google Scholar
• Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M, Fatho M, Lennerz V, Wölfel T, Hölzel M, et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 2012 490:412-6; PMID:23051752; http://dx.doi.org/10.1038/nature11538
   PubMed Web of Science ®Google Scholar
• Segura E, Valladeau-guilemond J, Donnadieu M-H, Sastre-garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med 2012 209:653-60; PMID:22430490; http://dx.doi.org/10.1084/jem.20111457
   PubMed Web of Science ®Google Scholar
• Bayerl C, Ueltzhöffer A, Jung EG. Langerhans cells enclosing sunburn cells in acute UV erythema in vivo. Arch Dermatol Res 1999 291:303-5; PMID:10367715; http://dx.doi.org/10.1007/s004030050413
   PubMed Web of Science ®Google Scholar
• Banchereau J, Thompson-Snipes L, Zurawski S, Blanck J-P, Cao Y, Clayton S, Gorvel J-P, Zurawski G, Klechevsky E. The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood 2012 119:5742-9; PMID:22535664; http://dx.doi.org/10.1182/blood-2011-08-371245
   PubMed Web of Science ®Google Scholar
• Banchereau J, Zurawski S, Thompson-Snipes L, Blanck J-P, Clayton S, Munk A, Cao Y, Wang Z, Khandelwal S, Hu J, et al. Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proc Natl Acad Sci U S A 2012 109:18885-90; PMID:23112154; http://dx.doi.org/10.1073/pnas.1205785109
   PubMed Web of Science ®Google Scholar
• Chu C-C, Ali N, Karagiannis P, Meglio Di P, Skowera A, Napolitano L, Barinaga G, Grys K, Sharif-Paghaleh E, Karagiannis SN, et al. Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med 2012 209:935-45; PMID:22547651; http://dx.doi.org/10.1084/jem.20112583
   PubMed Web of Science ®Google Scholar
• Wickman GR, Julian L, Mardilovich K, Schumacher S, Munro J, Rath N, Al Zander S, Mleczak A, Sumpton D, Morrice N, et al. Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs. Cell Death Differ 2013 20(10):1293-1305; PMID:23787996; http://dx.doi.org/10.1038/cdd.2013.69
   PubMed Web of Science ®Google Scholar
• Murshid A, Gong J, Calderwood SK. The role of heat shock proteins in antigen cross presentation. Front Immunol 2012 3:63; PMID:22566944; http://dx.doi.org/10.3389/fimmu.2012.00063
   PubMed Web of Science ®Google Scholar
• Li Y, Wang L-X, Pang P, Cui Z, Aung S, Haley D, Fox BA, Urba WJ, Hu, H-M. Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin Cancer Res 2011 17:7047-57; PMID:22068657; http://dx.doi.org/10.1158/1078-0432.CCR-11-0951
   PubMed Web of Science ®Google Scholar
• Yewdell JW. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol 2011 32:548-58; PMID:21962745; http://dx.doi.org/10.1016/j.it.2011.08.001
   PubMed Web of Science ®Google Scholar
• Van de Ven R, Lindenberg JJ, Oosterhoff D, de Gruijl T. D. Dendritic cell plasticity in tumor-conditioned skin: CD14(+) cells at the cross-roads of immune activation and suppression. Front Immunol 2013 4:403; PMID:24324467; http://dx.doi.org/10.3389/fimmu.2013.00403
   PubMedGoogle Scholar
• Molenkamp BG, Vuylsteke RJ, van Leeuwen PM, Meijer S, Vos W, Wijnands PG, Scheper RJ, de Gruijl TD. Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells. Am J Pathol 2005 167:1301-7; PMID:16251414; http://dx.doi.org/10.1016/S0002-9440(10)61217-5
   PubMed Web of Science ®Google Scholar
• Molenkamp BG, van Leeuwen PA, Meijer S, Sluijter BJ, Wijnands PG, Baars A, van den Eertwegh AJ, Scheper RJ, de Gruijl TD. Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients. Clin Cancer Res 2007 13:2961-9; PMID:17504997; http://dx.doi.org/10.1158/1078-0432.CCR-07-0050
   PubMed Web of Science ®Google Scholar
• Khan S, Weterings JJ, Britten CM, de Jong AR, Graafland D, Melief CJM, van der Burg SH, van der Marel G, Overkleeft HS, Filippov DV, et al. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells. Mol Immunol 2009 46:1084-91; PMID:19027958; http://dx.doi.org/10.1016/j.molimm.2008.10.006
   PubMed Web of Science ®Google Scholar
• Akiyama K, Ebihara S, Yada A, Matsumura K, Aiba S, Nukiwa T, Takai T. Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells. J Immunol 2003 170:1641-8; PMID:12574326; http://dx.doi.org/10.4049/jimmunol.170.4.1641
   PubMed Web of Science ®Google Scholar
• Auffermann-Gretzinger S, Eger L, Bornhäuser M, Schäkel K, Oelschlaegel U, Schaich M, Illmer T, Thiede C, Ehninger G. Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation. Transplantation 2006 81:866-73; PMID:16570010; http://dx.doi.org/10.1097/01.tp.0000203318.16224.57
   PubMed Web of Science ®Google Scholar
• Perreault C, Pelletier M, Landry D, Gyger M. Study of Langerhans cells after allogeneic bone marrow transplantation. Blood 1984 63:807-11; PMID:6367851
   PubMed Web of Science ®Google Scholar
• Vuylsteke RJ, Molenkamp BG, Gietema HA, van Leeuwen PA, Wijnands PG, Vos W, van Diest PJ, Scheper RJ, Meijer S, de Gruijl TD. Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma. Cancer Res 2004 64:8456-60; PMID:15548718; http://dx.doi.org/10.1158/0008-5472.CAN-03-3251
   PubMed Web of Science ®Google Scholar
• Van den Ancker W, van Luijn MM, Ruben JM, Westers TM, Bontkes HJ, Ossenkoppele GJ, de Gruijl TD, van de Loosdrecht AA. Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation. Cancer Immunol Immunother 2011 60:37-47; PMID:20859626; http://dx.doi.org/10.1007/s00262-010-0917-y
   PubMed Web of Science ®Google Scholar